Home » Topics » Conferences

Conferences
RSS

LMW inhibitor of Tat-TAR interaction and HIV replication prepared at Novartis

June 18, 1997

Dainippon Ink presents new antiallergic/antiasthmatic agent

June 18, 1997

Novel CCK-B antagonist with anxiolytic activity from Rotta

June 18, 1997

High-dose riboflavin for migraine prophylaxis

June 18, 1997

Targets for antimigraine therapy: SSRIs in the prevention of migraine

June 18, 1997

Targets for antimigraine therapy: NOS inhibitors as new therapeutic approach

June 18, 1997

Targets for antimigraine therapy: NK1 blockade not an effective antimigraine strategy

June 18, 1997

Targets for antimigraine therapy: inhibitors of neurogenic plasma protein extravasation

June 18, 1997

SKB describes development of 5-HT4 antagonists for IBS

June 16, 1997

Second-generation NNRTI under development by Hoechst/Bayer

June 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...